Safety and immunogenicity of a single-dose adenovirus-vectored rabies vaccine over 1 year in adults and children in Tanzania: interim data from an ongoing, partly randomised, controlled, phase 1b/2 trial
- DOI
- 10.1016/s1473-3099(26)00071-x
- Published
- 2026-08
- Container
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s1473-3099-26-00071-x,
title = {Safety and immunogenicity of a single-dose adenovirus-vectored rabies vaccine over 1 year in adults and children in Tanzania: interim data from an ongoing, partly randomised, controlled, phase 1b/2 trial},
author = {Adam J Ritchie and Omary Hassan and Nsiande Urasa and Paschal A Apanga and Rinter Kimathi and Wilmina F Kalinga and Ivanny M Mtaka and Reward G Lyimo and Moshi Moshi Shabani and Francisco Orliacq and Adam Berg and ZhiQuan Xiang and Saumu Ahmed and Thabit Athuman and Hildegund C J Ertl and Ally Olotu and Alexander D Douglas and Rose Paul Mkumbange and Ibrahim Sasamalo and Aina-Ekisha Kahatano and Safiness Daudi Mchome and Bakari Mwalimu Bakari and Neema Balige and Hania Msami and Mohamed Mohamed and Egbert Stanslaus Kenya},
year = {2026},
journal = {The Lancet Infectious Diseases},
doi = {10.1016/s1473-3099(26)00071-x},
url = {https://doi.org/10.1016/s1473-3099(26)00071-x}
}RIS
TY - JOUR TI - Safety and immunogenicity of a single-dose adenovirus-vectored rabies vaccine over 1 year in adults and children in Tanzania: interim data from an ongoing, partly randomised, controlled, phase 1b/2 trial AU - Adam J Ritchie AU - Omary Hassan AU - Nsiande Urasa AU - Paschal A Apanga AU - Rinter Kimathi AU - Wilmina F Kalinga AU - Ivanny M Mtaka AU - Reward G Lyimo AU - Moshi Moshi Shabani AU - Francisco Orliacq AU - Adam Berg AU - ZhiQuan Xiang AU - Saumu Ahmed AU - Thabit Athuman AU - Hildegund C J Ertl AU - Ally Olotu AU - Alexander D Douglas AU - Rose Paul Mkumbange AU - Ibrahim Sasamalo AU - Aina-Ekisha Kahatano AU - Safiness Daudi Mchome AU - Bakari Mwalimu Bakari AU - Neema Balige AU - Hania Msami AU - Mohamed Mohamed AU - Egbert Stanslaus Kenya PY - 2026 JO - The Lancet Infectious Diseases DO - 10.1016/s1473-3099(26)00071-x UR - https://doi.org/10.1016/s1473-3099(26)00071-x ER -
APA
Ritchie, A. J., Hassan, O., Urasa, N., Apanga, P. A., Kimathi, R., Kalinga, W. F., Mtaka, I. M., Lyimo, R. G., Shabani, M. M., Orliacq, F., Berg, A., Xiang, Z., Ahmed, S., Athuman, T., Ertl, H. C. J., Olotu, A., Douglas, A. D., Mkumbange, R. P., Sasamalo, I., Kahatano, A., Mchome, S. D., Bakari, B. M., Balige, N., Msami, H., Mohamed, M., & Kenya, E. S. (2026). Safety and immunogenicity of a single-dose adenovirus-vectored rabies vaccine over 1 year in adults and children in Tanzania: interim data from an ongoing, partly randomised, controlled, phase 1b/2 trial. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(26)00071-x
Source records
- crossref · retrieved 2026-09-27T14:05:41.278Z